Adriana Sánchez Danés, PhD, Cancer and Stem Cell Biology Lab
Seminar room
In this seminar, I will present recent advances developed in our laboratory in CAR-based adoptive T-cell immunotherapy, with a particular focuss on leukemia. The talk will highlight γδ T cells as allogeneic effector platforms and explore emerging dual-targeting and armored CAR strategies.
Location and Dates: Champalimaud Foundation, 13 to 17 April 2026
Application Deadline: 22 February 2026
Acceptance Notification: 24 February 2026
Cost: 300 Euros + VAT (23%) (payment deadline 2 March 2026). The fee includes coffee-breaks, lunches and the course dinner on 16 April 2026.
Candidate Attendance Confirmation Deadline: 2 March
Capacity: 16 participants